Skip to main content
Caplight Logo









HB Biotech

HB Biotech

Private
AraraquaraHealthcare & Life Scienceshttps://www.hbbiotech.com.br/

Last Round

Accelerator

Jul 1, 2023

Total Funding Raised

$191,000

Company Overview

HB Biotech is a biotechnology company that specializes in the industrial-scale production of bacterial cellulose for applications in the medical, pharmaceutical, food, and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

superabsorbent polymerbiotechnologymedical deviceweight managementmetabolic healthmedtechheart failure treatmentchronic kidney diseaseGI tract absorptionweight loss supplementhealth supplementsD2C healthnon-invasive treatmentbiohacking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HB Biotech Comparables

Compare HB Biotech with similar companies based on industry and business-model similarity.

HB Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Theras Group
71%
Sanofi
69%
Glyscend Therapeutics
66%

HB Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 1, 2023
GrantAug 17, 2022

HB Biotech Investors

Notable investors and investment history

HB Biotech investors
InvestorRounds
Suzano VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors increased 148% MoM.

  • Apr 23, 2026

    Monthly visitors grew 72% MoM.

HB Biotech Filings

Explore SEC and related filing metadata, where available.

HB Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HB Biotech's valuation, stock price, and market status.

Is HB Biotech a public or private company?

HB Biotech is a private company.

What is the current stock price of HB Biotech?

HB Biotech is a private company with no public stock price. Caplight tracks HB Biotech's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is HB Biotech worth (valuation)?

Valuation information for HB Biotech is not publicly available.

Can I buy HB Biotech stock?

HB Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HB Biotech's last funding round?

HB Biotech's most recent funding round was Accelerator on July 1, 2023.

Who are the main investors in HB Biotech?

Key investors in HB Biotech include Suzano Ventures.

Will HB Biotech IPO soon?

No public IPO plans have been announced for HB Biotech.

How can I track HB Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HB Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAraraquara
Employee Range4
Year FoundedN/A
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?